11 Master positions at Institute of Bioorganic Chemistry Polish Academy of Sciences in Poland
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
: Investigation of posttranscriptional processes in retrotransposon biology Principal Investigator: dr. hab. Zbigniew Warkocki Project description: We offer the position of student or a PhD student within National
-
, transcriptomics, spinocerebellar ataxia 3, mutant protein, PolyQ, therapy. Principal Investigator: Maciej Figiel Research topic: Investigation of molecular mechanisms of dietary intervention on neurodegeneration in
-
) Principal Investigator: Prof. Ryszard Kierzek Project description RNAs are one of the most important biomolecules. In RNA, beside canonical nucleotides, are over 140 modified ones. The most abundant are N6
-
WORDS: RNA, LINE-1 retrotransposons, post-transcriptional regulation of gene expression, Principal Investigator: dr hab. Zbigniew Warkocki, prof. ICHB PAN Research topic: The Institute of Bioorganic
-
, safety, gene therapy, DNA repair Principal Investigator: Marta Olejniczak, PhD, Associate Professor of IBCH PAS Research topic: “Assessing efficacy and safety of genome EDITing approaches for Sickle Cell
-
Principal Investigator: dr Katarzyna Klonowska Research topic: We offer the position of an Assistant Professor (post-doc) within OPUS 25 (2023/49/B/NZ5/03438) project, entitled “Ultrasensitive profiling
-
: microsatellite sequences, CAG repeats, DNA repair, neurodegenerative diseases, gene therapy Research topic: Investigation of the mechanisms of short tandem repeats instability Principal Investigator: Marta
-
Description KEYWORDS: neurodegenerative disease, nutrition, neurodegeneration, mechanisms, multiomics, proteomics, transcriptomics, spinocerebellar ataxia 3, mutant protein, PolyQ, therapy. Principal
-
Description KEYWORDS: neurodegenerative disease, brain, spinocerebellar ataxia 3, mutant protein, PolyQ, autophagy, proteasome, therapy, small molecules, preclinical drug testing, small molecule drugs Principal
-
KEYWORDS: neurodegenerative disease, brain, mutant protein, PolyQ, autophagy, proteasome, therapy, small molecules, preclinical drug testing, small molecule drugs, spinocerebellar ataxia 3, SCA3 Principal